Skip to main content

MoneyWorks4Me

The total revenue for the quarter ended December 2023 remained nearly unchanged at Rs. 2880.00 millions.The Net Loss for the quarter ended December 2023 is Rs. -740.00 millions as compared to Net Loss of Rs. -550.00 millions of corresponding quarter ended December 2022The company reported a degrowth in operating Profit to 300.00 millions from 440.00 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202312 202212 % Var 202312 202212 % Var 202303 202203 % Var
Sales 2880.00 2820.00 2.13 7990.00 7810.00 2.30 10720.00 13720.00 -21.87
Other Income 50.00 180.00 -72.22 170.00 960.00 -82.29 670.00 380.00 76.32
PBIDT 300.00 440.00 -31.82 270.00 1380.00 -80.43 1370.00 2600.00 -47.31
Interest 610.00 520.00 17.31 1780.00 1710.00 4.09 2290.00 2730.00 -16.12
PBDT -310.00 -80.00 287.50 -1650.00 -830.00 98.80 -3270.00 -130.00 2415.38
Depreciation 430.00 470.00 -8.51 1310.00 1410.00 -7.09 1860.00 1710.00 8.77
PBT -740.00 -550.00 34.55 -2960.00 -2240.00 32.14 -5130.00 -1840.00 178.80
TAX 0.00 0.00 0.00 0.00 -570.00 0.00 -470.00 -440.00 6.82
Deferred Tax 0.00 0.00 0.00 0.00 -570.00 0.00 -470.00 -490.00 -4.08
PAT -740.00 -550.00 34.55 -2960.00 -1670.00 77.25 -4660.00 -1400.00 232.86
Equity 720.00 720.00 0.00 720.00 720.00 0.00 720.00 720.00 0.00
PBIDTM(%) 10.42 15.60 -33.24 3.38 17.67 -80.88 12.78 18.95 -32.56
Peers
Company Name CMP
Sun Pharma. Inds. 1880.90
Dr. Reddys Labs. 1377.00
Cipla 1393.00
Lupin 1980.00
Zydus Lifesciences 1191.00
View more..